comparemela.com

Latest Breaking News On - Legend biotech co - Page 1 : comparemela.com

Legend Biotech (NASDAQ:LEGN) Shares Down 6%

Legend Biotech (NASDAQ:LEGN) Shares Down 6%
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Canada
Massachusetts
United-states
China
Raymond-james
Sumitomo-mitsui-trust-holdings-inc
Royal-bank
Massachusetts-financial-services-co
Cantor-fitzgerald
Legend-biotech-corporation
Timessquare-capital-management
Legend-biotech-co

Q4 2025 EPS Estimates for Legend Biotech Co. Decreased by Analyst (NASDAQ:LEGN)

Legend Biotech Co. (NASDAQ:LEGN – Free Report) – Research analysts at HC Wainwright lowered their Q4 2025 earnings per share (EPS) estimates for shares of Legend Biotech in a note issued to investors on Friday, May 24th. HC Wainwright analyst M. Kapoor now expects that the company will earn $0.10 per share for the quarter, […]

China
Texas
United-states
Canada
American
Raymond-james
Nasdaq
Us-bancorp
Legend-biotech-co
Royal-bank
Deutsche-bank-aktiengesellschaft
Legend-biotech-corporation

HC Wainwright Research Analysts Decrease Earnings Estimates for Legend Biotech Co. (NASDAQ:LEGN)

Legend Biotech Co. (NASDAQ:LEGN – Free Report) – Investment analysts at HC Wainwright decreased their Q4 2025 earnings per share (EPS) estimates for Legend Biotech in a report released on Friday, May 24th. HC Wainwright analyst M. Kapoor now anticipates that the company will post earnings per share of $0.10 for the quarter, down from […]

United-states
Canada
Texas
China
American
Raymond-james
Vanguard-personalized-indexing-management
Scotiabank
Avior-wealth-management
Nasdaq
Us-bancorp
American-international-group-inc

Legend Biotech (LEGN) – Investment Analysts' Recent Ratings Changes

A number of firms have modified their ratings and price targets on shares of Legend Biotech (NASDAQ: LEGN) recently: 5/24/2024 – Legend Biotech had its price target lowered by analysts at HC Wainwright from $86.00 to $73.00. They now have a “buy” rating on the stock. 5/23/2024 – Legend Biotech is now covered by analysts […]

Canada
Switzerland
United-states
China
Texas
Swiss
Royal-bank
Legend-biotech-corporation
Kokusai-asset-management-co
Scotiabank
Cantor-fitzgerald

Westfield Capital Management Co. LP Boosts Position in Legend Biotech Co. (NASDAQ:LEGN)

Westfield Capital Management Co. LP grew its position in shares of Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 6.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,776,247 shares of the company’s stock after purchasing an additional 108,097 […]

China
United-states
Handelsinvest-investeringsforvaltning
Deutsche-bank-aktiengesellschaft
Cantor-fitzgerald
Legend-biotech-corporation
Legend-biotech-co
Westfield-capital-management-co
Financial-services-group-inc
Vanguard-personalized-indexing-management
Daiwa-securities-group-inc
Nasdaq

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.